Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 8, 2012Critical Care MedicineOpen Access

Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor*

View Full Paper
Ask AI
Bookmark
Share

Authors

SRSebastian RehbergCARE USAPEPerenlei EnkhbaatarThe University of Texas Medical Branch at GalvestonJRJanina Rehberg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rehberg et al. (2012) studied this question.

synapsesocial.com/papers/6a6f2b4ab27f15817826e39bhttps://doi.org/10.1097/ccm.0b013e31824e0fe5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 20082007 · 4,948 citations
  2. 2Differential Role of von Willebrand Factor and P-Selectin on Microvascular Thrombosis in Endotoxemia2008 · 34 citations
  3. 3Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 20082008 · 3,939 citations
  4. 4Elevated Circulating E-Selectin, Intercellular Adhesion Molecule 1, and von Willebrand Factor in Patients with Severe Infection1998 · 212 citations
  5. 5Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock2008 · 1,929 citations